MADISON, WI —
OSHA Inspection: WOMEN'S INTERNATIONAL PHARMACY, INC.
Referral inspection · Health discipline
At a glance
On , OSHA opened a referral health inspection of WOMEN'S INTERNATIONAL PHARMACY, INC. in 5708 MONONA DRIVE, MADISON, WI 53716 (NAICS 000000). OSHA activity number 300569555.
OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.
Where did this inspection happen?
- Establishment
- WOMEN'S INTERNATIONAL PHARMACY, INC.
- Site address
- 5708 MONONA DRIVE
- City
- MADISON
- State
- WI
- ZIP
- 53716
- Mailing
- 2 MARSH COURT, MADISON, WI 53718
What kind of inspection was it?
- Inspection type
- Referral (C)
- Scope
- Partial (B)
- Discipline
- Health
- Advance notice
- No
- Union status
- N
When did the case open and close?
- Opened
- Closing conference
- Case closed
- Last modified
- Data loaded
Establishment context
- NAICS code
- 000000
- SIC code (legacy)
- 2834
- Employees
- 80
- Ownership type
- A
Citations
11 citations on file for this inspection.
5(a)(1)
- Issued
- Apr 6, 2000
- Abate by
- Jul 31, 2004
- Penalty
- Initial $2,450 · Current $2,450
Recent events (2)
- — P (S) $2450.00
- — Z (S) $2450.00
1910.134 D01 III
- Issued
- Apr 6, 2000
- Abate by
- Apr 12, 2000
5(a)(1)
- Issued
- Mar 17, 2000
- Abate by
- May 31, 2000
- Penalty
- Initial $3,500
General-duty citation text
Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The employer did not furnish employment and a place of employment which were free from recognized hazards that were causing or likely to cause death or serious physical harm to employees in that employees were exposed to the hazards associated with the reproductive toxicant progesterone: a. Employee compounding medication containing hormones, such as but not limited to progesterone, was exposed to 15.5 micrograms/cubic meter of progesterone or 1.24 times the 8-hour time weighted exposure average recommended exposure limit (REL) of 12.5 micrograms/cubic meter as listed by a manufacturer, Upjohn. Sampling was conducted for 393 minutes on 11/24/99. The unsampled period was taken as zero exposure. b. Employee compounding medication containing hormones, such as but not limited to progesterone, was exposed to 14.6 micrograms/cubic meter of progesterone or 1.16 times the 8-hour time weighted exposure average recommended exposure limit (REL) of 12.5 micrograms/cubic meter as listed by a manufacturer, Upjohn. Sampling was conducted for 412 minutes on 11/24/99. The unsampled period was taken as zero exposure. c. Employee compounding medication containing hormones, such as but not limited to progesterone, was exposed to 6.8 micrograms/cubic meter of progesterone or 0.54 times the 8- hour time weighted exposure average recommended exposure limit (REL) of 12.5 micrograms/cubic meter as listed by a manufacturer, Upjohn. Sampling was conducted for 394 minutes on 11/24/99. "AMONG OTHER METHODS, ONE FEASIBLE AND ACCEPTABLE ABATEMENT METHOD TO CORRECT THIS HAZARD IS...." 1. Install engineering controls with local exhaust ventilation connected to high efficiency purifying air filters, such as but not limited to glove boxes. The process should be totally enclosed preventing leakage into the work area. 2. Implementation of work practice and administrative controls. Work area access should be controlled minimizing exposure. Dry sweeping of work area prohibited 3. Development and implementation of decontamination procedures following "dusty" procedures. 4. Implementation of good hygiene practices and prohibition of eating, drinking, smoking and applying cosmetics in work area. 5. development and implementation of cleaning procedures for contaminated (or potentially contaminated) work surfaces.
Recent events (2)
- — I (S)
- — Z (S) $3500.00
5(a)(1)
- Issued
- Mar 17, 2000
- Abate by
- Jul 31, 2004
- Penalty
- Initial $3,500 · Current $2,450 Reduced
General-duty citation text
Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The employer did not furnish employment and a place of employment which were free from recognized hazards that were causing or likely to cause death or serious physical harm to employees in that employees were exposed to the hazards associated with surface contamination and dermal absorption of reproductive toxicants, such as but not limited to progesterone, estradiol, estriol, and testosterone: Key board and keyboard area in the lab leader area had: 21.2 to 287.8 micrograms of progesterone, 0 to 2.7 micrograms of estradiol, 0 to 7.10 micrograms of estriol, and 0 to 29.7 micrograms testosterone on it. "AMONG OTHER METHODS, ONE FEASIBLE AND ACCEPTABLE ABATEMENT METHOD TO CORRECT THIS HAZARD IS...." 1. Installation of engineering controls with local exhaust ventilation connected to high efficiency purifying air filters, such as but not limited to glove boxes. The process should be totally enclosed preventing leakage into the work area. 2. Implementation of work practice and administrative controls. Work area access should be controlled minimizing exposure. Dry sweeping of work area prohibited 3. Development and implementation of decontamination procedures following "dusty" procedures. 4. Development and implementation of cleaning procedures for contaminated (or potentially contaminated) work surfaces.
Recent events (3)
- — P (S) $2450.00
- — I (S) $2450.00
- — Z (S) $3500.00
1910.134 A02
- Issued
- Mar 17, 2000
- Abate by
- Mar 24, 2000
- Penalty
- Initial $1,750 · Current $1,750
Recent events (2)
- — I (S) $1750.00
- — Z (S) $1750.00
1910.134 D01 III
- Issued
- Mar 17, 2000
- Abate by
- Mar 22, 2000
Recent events (2)
- — I (S)
- — Z (S)
1910.134 C01
- Issued
- Mar 17, 2000
- Abate by
- Apr 19, 2000
- Penalty
- Initial $1,050 · Current $600 Reduced
Recent events (2)
- — I (S) $600.00
- — Z (S) $1050.00
1910.134 D03 II
- Issued
- Mar 17, 2000
- Abate by
- Apr 19, 2000
Recent events (2)
- — I (S)
- — Z (S)
1910.305 B02
- Issued
- Mar 17, 2000
- Abate by
- Mar 23, 2000
- Penalty
- Initial $1,100
Recent events (2)
- — I (O)
- — Z (S) $1100.00
1910.305 J01 I
- Issued
- Mar 17, 2000
- Abate by
- Mar 22, 2000
Recent events (2)
- — I (S)
- — Z (S)
1910.1200 E01
- Issued
- Mar 17, 2000
- Abate by
- May 31, 2000
- Penalty
- Initial $500
Recent events (2)
- — I (O)
- — Z (O) $500.00
More inspections at Women'S International Pharmacy, INC.
View Women'S International Pharmacy, INC.'s full OSHA safety record →
More inspections in this industry (NAICS 000000)
More inspections in WI
Source
This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 300569555.
Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.